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The  efﬁcacy  of  eprinomectin  in  an  extended-release  injection  (ERI)  formulation  was  eval-
uated  against  infections  with  third-stage  larvae  or eggs  of  gastrointestinal  and  pulmonary
nematodes  in  cattle  under  120-day  natural  challenge  conditions  in  a  series  of  ﬁve  stud-
ies conducted  in  the USA  (three  studies)  and  in  Europe  (two  studies).  For each  study,  30
nematode-free  (four  studies)  or 30 cattle  harboring  naturally  acquired  nematode  infec-
tions (one  study)  were  included.  The  cattle  were  of  various  breeds  or crosses,  weighed
107.5–273  kg  prior  to treatment  and  aged  approximately  4–11  months.  For  each  study,
animals  were  blocked  based  on  pre-treatment  bodyweight  and  then  randomly  allocated  to
treatment:  ERI  vehicle  (control)  at  1  mL/50  kg  bodyweight  or Eprinomectin  5% (w/v)  ERI at
1 mL/50  kg  bodyweight  (1.0  mg  eprinomectin/kg)  for  a total  of  15 and  15 animals  in each
group.  Treatments  were  administered  once  on  Day  0 by subcutaneous  injection  in  front  of
the  shoulder.  In  each  study,  all animals  grazed  one  naturally  contaminated  pasture  for 120
days. At regular  intervals  during  the  studies,  fecal  samples  from  all  cattle  were  examined  for
nematode  egg  and  larval  counts.  In four studies  pairs  of  tracer  cattle  were  used  to monitor
pasture infectivity  at 28-day  intervals  before  and/or  during  the  grazing  period.  All  calves
were  weighed  before  turnout  onto  pasture  and  at  regular  intervals  until  housing  on  Day
120. For  parasite  recovery,  all study  animals  were  humanely  euthanized  27–30  days  after
removal from  pasture.
Cattle  treated  with  Eprinomectin  ERI  had  signiﬁcantly  (p  <  0.05)  fewer  strongylid  eggs
(≤1 egg  per gram;  egg  count  reduction  ≥  94%)  than  the  control  cattle  and  zero  lungworm
larvae  at  each  post-treatment  time  point.  At euthanasia,  cattle  treated  with  Eprinomectin
ERI  had  signiﬁcantly  (p < 0.05)  fewer  of  the  following  nematodes  than  the ERI  vehicle-
treated  (control)  cattle  with  overall  reduction  of  nematode  counts  by >92%:  Dictyocaulus
viviparus  (adults  and  fourth-stage  larvae  (L4),  Bunostomum  phlebotomum, Cooperia  cur-
ticei, Cooperia  oncophora,  Cooperia  punctata,  Cooperia  surnabada,  Cooperia  spp.  inhibited
L4, Haemonchus  contortus,  Haemonchus  placei,  Haemonchus  spp.  inhibited  L4,  Nematodirus
odirus  spp.  inhibited  L4,  Oesophagostomum  radiatum,  Oesophagostomumhelvetianus,  Nemat
spp.  inhibited  L4, Ostertagia  leptospicularis, Ostertagia  lyrata, Ostertagia  ostertagi,  Osterta-
gia spp. inhibited  L4,  Trichostrongylus  axei,  Trichostrongylus  colubriformis,  Trichostrongylus
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spp.  inhibited  L4,  Trichuris  discolor,  and Trichuris  ovis.  Over  the  120-day  grazing  period,
Eprinomectin  ERI-treated  cattle  gained  between  4.8 kg  and  31  kg more  weight  than  the
controls.  This  weight  gain  advantage  was  signiﬁcant  (p <  0.05)  in three  studies.
All  animals  accepted  the treatment  well.  No adverse  reaction  to treatment  was  observed
y  studin  any  animal  in  an
1. Introduction
Collectively, gastrointestinal nematodes and lung-
worms are still considered the most commonly occurring
and  most economically important parasites of grazing cat-
tle  in temperate regions worldwide.
Although parasitic infections in the majority of the
cattle are often subclinical in current management sys-
tems  where antiparasitics are used for prophylactic control,
infection with those parasites can cause severe parasitic
gastroenteritis and parasitic bronchitis, especially in young
stock  which are most susceptible in their ﬁrst grazing
season. Knowledge of the epidemiology of parasitic nema-
todes  has led to the creation of parasite control programs
which aim to suppress the fecal egg output of grazing cat-
tle  by the use of early season anthelmintic prophylaxis
and thus reduce the accumulation of infective larvae in
the  environment later in the season. The repeated strategic
(prophylactic) administration of anthelmintics has proven
to  be highly effective in the prevention of clinical dis-
ease  and/or production losses. The superior efﬁcacy and
extended duration of activity of the macrocyclic lactones
in  injectable and pour-on formulations led to an impor-
tant  extension of the intervals between treatments in these
programs. High labor and equipment costs resulting from
frequent  gathering of cattle for treatment administration
resulted in the development of various forms of intrarumi-
nal  boli (controlled-release devices) that were formulated
for  delivery of anthelmintics for up to 4 months follow-
ing  a single administration, either by continuous low-level
release or by pulse-release of the drug.
The endectocidal effectiveness of eprinomectin, the
most  recent commercialized member of the macrocyclic
lactone class of parasiticides as used in a 0.5% pour-on for-
mulation  at 0.5 mg  eprinomectin/kg bodyweight, has been
extensively documented (Barth et al., 1997; Gogolewski
et al., 1997a,b; Holste et al., 1997, 1998; Pitt et al., 1997;
Williams et al., 1997; Yazwinski et al., 1997; Campbell
et al., 2001; Davey and George, 2002; Rehbein et al., 2005).
Dose  titration studies have demonstrated eprinomectin
represents a threefold greater potency against ruminant
gastrointestinal nematodes than ivermectin (Shoop et al.,
1996;  Shoop and Soll, 2002). The commercialized epri-
nomectin pour-on formulation has considerable persistent
activity against a range of important nematodes (Cramer
et  al., 2000; Holste et al., 2002) and has been used success-
fully in prophylactic treatment programmes (Batty et al.,
1999;  Epe et al., 1999; Dorny et al., 2000).In order to extend the persistency of activity of epri-
nomectin against endoparasites, an injectable formulation
has been developed which is not only effective in removing
existing nematode infections (Hunter et al., 2013; Rehbeiny.
© 2012 Elsevier B.V. 
et  al., 2013) but also releases the active ingredient in
concentrations to provide effective control of nematode
infections in cattle for up to 150 days after treatment as
demonstrated in single point challenge studies (Soll et al.,
2013).  In this extended-release formulation, eprinomectin
is  released from a matrix formed with poly(d,l-lactide-
co-glycolic)acid (PLGA). PLGA is known as a safe and
effective biodegradable material which has been used
as  a drug delivery system for extended release appli-
cations of various pharmaceutical compounds including
ivermectin (Lewis, 1990; Miller et al., 1999; Clark et al.,
2004;  Winzenburg et al., 2004).
The studies reported here were designed to conﬁrm
the efﬁcacy of eprinomectin extended-release injection
(ERI) over the entire duration of activity of the product,
i.e., nematode-free or naturally infected calves received a
single  injection of eprinomectin ERI at turnout and were
subsequently and continuously exposed to nematode chal-
lenge  by grazing permanent pasture for 120 days.
2.  Materials and methods
A  total of ﬁve controlled studies were conducted accord-
ing  to similar protocols, three in the USA and one each
in  Germany and in the UK. In four studies (Studies 1–4),
nematode-free calves were used, while one study utilized
calves  harboring naturally acquired nematode infections
(Study 5). The studies were designed and conducted to
comply  with the regulatory requirements of both the
FDA/CVM and the European Medicines Agency/Committee
for Medicinal Products for Veterinary Use, and according to
relevant  guidelines for Good Clinical Practices (GCPs) and
for  establishing the efﬁcacy of cattle anthelmintics.
The studies were performed as blinded studies, i.e., all
personnel involved in collecting data were masked to the
treatment assignment of the animals.
2.1. Experimental animals
A  total of 150 (67 male castrate, 83 female) healthy,
ruminating Holstein, Limousin, Pinzgauer and cross-bred
beef cattle, weighing 107.5–273 kg prior to treatment (Days
−3,  −1 or 0), and aged approximately 4–11 months were
included in ﬁve studies conducted in the USA (Studies 3, 4,
and  5 – Arkansas, Idaho, Missouri), in Germany (Study 2,
Upper  Bavaria), and in the UK (Study 1, Hertfordshire). The
animal  descriptions and details are presented in Table 1.
Animals  had not been previously treated with an aver-
Open access under CC BY-NC-ND license. mectin or milbemycin product.
Animals enrolled in Studies 1–4 were worm-free (as
determined by fecal examination prior to study start, i.e.,
Days  −15 or −14), with the exception of one animal in
S. Rehbein et al. / Veterinary Parasitology 192 (2013) 321– 331 323
Table 1
Animal description and details.
Study#a Treatmentb/animals
per treatment
Breed Sex ∼Age (months) Pre-treatment
bodyweight (kg)
1 Control, n = 15 Limousin, Female 4–6 107.5–199
EpERI, n = 15 Limousin cross, Salers cross
2 Control, n = 15 Pinzgauer Male castrate 6 117–178
EpERI, n = 15
3 Control, n = 15 Mixed stocker breeds Female 6 143.8–182.3
EpERI, n = 15
4 Control, n = 15 Holstein Male castrate 5 192.3–240.4
EpERI, n = 15
5 Control, n = 15 Angus, Angus cross, Charolais, 6 Male castrate, 24 9–11 190–276
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a Study sites: Study 1 – Hertfordshire, UK; Study 2 – Upper Bavaria, Ge
b Control, ERI vehicle-treated; EpERI, Eprinomectin ERI.
tudy 3, which shed 2 strongylid eggs per gram on Day
 (=day of treatment). Calves included in Studies 1 and 2
ere nematode-naïve while calves used in Studies 3 and 4
ere treated with fenbendazole (10 mg/kg bodyweight per
s) on Day −21 before pre-treatment fecal examination on
ay −14.
Animals used in Study 5 harbored naturally acquired
ematode infections and were shedding 1.33–321
trongylid eggs per gram of feces at examination on
ay −7.
For proof of pasture infectivity (pasture contamina-
ion), eight to ten tracer cattle were included in Studies
–4 (see Tables 3–6). The tracer cattle were similar to the
tudy animals and were demonstrated free of patent nema-
ode infection as conﬁrmed by fecal examination prior to
urnout onto pasture.
All animals were handled with due regard to their wel-
are and in compliance with Merial Institutional Animal
are and Use Committee (IACUC) approvals, any applicable
ocal regulations, and requirements of any local IACUC.
.2. Study design
Studies 1–4 were conducted under the same proto-
ol design utilizing a randomized block design based on
re-treatment (Day −1 or 0) bodyweights such that 15
eplicates of two cattle each were formed sequentially.
ithin replicates, animals were randomly allocated to
reatment: one to the control (ERI vehicle-treated) group
nd one to the Eprinomectin ERI group, for a total of 15
nd 15 animals in each group. For Study 5, a total of 75
attle were ranked by pre-treatment (Day −3) bodyweight
rouped into replicates of ﬁve animals each, and randomly
llocated to one of ﬁve treatment groups within each repli-
ate: control (ERI vehicle-treated) group, Eprinomectin ERI
roup, and three animals to one of three other additional
reatment groups (data not shown), for a total of 15 animals
er treatment group. All studies were initiated in June.
Treatments, ERI vehicle (formulation that consisted
f the excipients of the Eprinomectin ERI) as well as
prinomectin ERI (eprinomectin 5% in a PLGA-based for-
ulation), were administered at 1 mL/50 kg (1 mL/110 lb)
odyweight once on Day 0 by subcutaneous injection inFemale
Study 3 – Arkansas, USA; Study 4 – Idaho, USA; Study 5 – Missouri, USA.
front of the shoulder using commercial syringes and nee-
dles. Dose volumes were rounded to the next 0.1 mL  above
the calculated dose volume if the bodyweight was between
increments.
All cattle were observed hourly for 4 h post-treatment
and thereafter once daily throughout the studies for health
problems or adverse drug events.
All study animals were weighed prior to treatment (Day
−3 or −1 or 0) for allocation and dose calculation, and on
Days 28, 56, 84, and 120.
To provide an indication of the level of contamination of
the pasture with helminth larvae/eggs, pairs of worm-free
tracer calves were placed in the same pasture as the study
animals (principals) for approximately 28-day intervals
in Studies 1–4. The tracer calves were humanely euth-
anized immediately after removal from pasture or after
housing for up to three weeks under conditions which
were designed to preclude further nematode infections (for
details see Tables 3–6).
In all studies, control (ERI vehicle-treated) and Epri-
nomectin ERI-treated cattle grazed the same naturally
contaminated pasture to ensure continuous nematode
exposure. After 120 days, the animals were housed under
conditions designed to preclude further nematode expo-
sure. All study animals were humanely euthanized 27–30
days later for nematode recovery.
2.3. Parasitological techniques
2.3.1. Fecal examinations
In Studies 1–4, fecal samples were collected from all
study animals on Day 0 before treatment and on Days 28,
56, 84, and 120 after treatment for fecal egg and lung-
worm larval count determination. For fecal egg counting
either a modiﬁed McMaster method (ﬂotation using sat-
urated NaCl solution; count sensitivity 1 egg ≡ 50 eggs
per gram (EPG) in Study 1 or 1 egg ≡ 10 EPG in Study
2) or a quantitative direct centrifugation/ﬂotation tech-
nique (Study 3: ﬂotation using saturated MgSO4 solution,
count sensitivity 1 egg ≡ 2 EPG; Study 4: ﬂotation using
saturated NaCl solution, count sensitivity 1 egg ≡ 10 EPG)
was used. For lungworm (Dictyocaulus) larval recovery, the
Baermann technique was  used based on 10-g fecal samples.
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When present, eggs were referred to as strongylid (nema-
tode genera including Bunostomum, Cooperia, Haemonchus,
Oesophagostomum, Ostertagia,  and Trichostrongylus), Nema-
todirus, Strongyloides, Capillaria, and/or Trichuris eggs.
In Study 5, fecal samples were collected from all
study animals on Day −7 (prior to treatment) and on
Days 28, 56, 84, and 120 after treatment for fecal
egg count determination using a double centrifuga-
tion/ﬂotation technique (ﬂotation using Sheather’s sucrose
solution; count sensitivity 1 egg ≡ 0.33 EPG). Fecal lung-
worm (Dictyocaulus) larval counts using the Baermann
technique based on 50-g fecal samples were conducted
only on Day −7. When present, eggs were referred to
as strongylid (nematode genera including Bunostomum,
Cooperia, Haemonchus, Nematodirus, Oesophagostomum,
Ostertagia, and Trichostrongylus), Strongyloides, Capillaria,
and/or Trichuris eggs.
2.3.2. Pepsinogen determination
Plasma derived from blood samples collected on Days
−1, 28, 56, 84, and 120 from Study 2 animals was  analyzed
for pepsinogen concentration using the method of Berghen
et al. (1987).
2.3.3. Parasite counts
All study animals were humanely euthanized for nema-
tode counting 27–30 days after removal from pasture. At
necropsy, the lungs, abomasum, small intestine, and large
intestine were removed. Lungs were examined completely
for lungworms either by lengthwise opening of all accessi-
ble air passages and soaking of the dissected lungs (Studies
2 and 3) or by pulmonary tract perfusion (Oakley, 1980;
Studies 1, 4 and 5). The contents of the abomasum, small
and large intestines were collected separately and diluted
with water. Abomasum and small intestine were incubated
(saline soak) to recover mucosal stages of the parasites for
identiﬁcation and counting. The entire contents or a known
percentage of the contents of each organ (abomasum and
small intestine contents: 5% aliquots; abomasum and small
intestine soaks: 2%, 5% or 10% aliquots; large intestine con-
tent: 5%, 20%, 25% aliquots or total count) were examined
and the appropriate dilution factor applied to calculate the
ﬁnal count. To facilitate isolation and counting of nema-
todes, organ contents and soaks were screened over sieves
of appropriate mesh sizes to remove the debris.
Counts of each parasite species for each animal were
calculated by multiplying the number of worms actually
counted from each organ by the aliquot factor and summing
over all organs.
At necropsy, nematodes were identiﬁed to species or
genus level and stage of development according to recog-
nized methods and procedures. Adult female nematodes
and/or fourth-stage larvae were not identiﬁed always to
species level. For some genera of nematodes (e.g., Coope-
ria, Ostertagia,  and Trichostrongylus), the total counts were
estimated by proportionally assigning adult females to
each species based on the adult male counts. When adult
females within genera were counted in the presence of
no males, the counts were either proportioned equally or
assigned based on the species present in other animals.
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nematodes were assigned to species based on the location
in which the nematodes were found.
Necropsies of the tracer calves followed the same princi-
ples as described for the study animals; however, the sizes
of examined aliquots were different in some cases.
2.4. Statistical methods
Fecal eggs per gram counts or Dictyocaulus larval
counts per gram for each animal at each time point were
transformed to the natural logarithm of (count + 1) for
calculation of geometric means. Exclusion criterion for
individual analysis for Nematodirus, Strongyloides, Capil-
laria, Trichuris, and/or Dictyocaulus egg or larval counts was
based on an infection rate (prevalence) of <40% in the con-
trol (ERI vehicle-treated) animals at the post-treatment
time points.
Efﬁcacy was calculated as percent reduction in
egg/larval counts at each time point as 100[(C − T)/C],
where C is the geometric mean of the control group and
T is the geometric mean of the Eprinomectin ERI-treated
group.
All nematode counts were subject to the methods
described above regarding transformation and calculation
of geometric means and efﬁcacy. Treatment groups were
compared using the Wilcoxon rank sum test. A two-sided
test was used at ˛ = 0.05.
Pepsinogen concentrations were analyzed with a
repeated-measures analysis of variance (ANOVA) method
in a randomized block design.
Pre-treatment bodyweight, Day 120 bodyweight, and
weight gain until removal of animals from pasture (Day
120) were analyzed using ANOVA for a randomized block
design.
3. Results
All animals accepted treatment, Eprinomectin ERI or ERI
vehicle (control), well, as they were reported as normal
during hourly observations for four hours post-treatment.
There were no drug-related health problems or adverse
drug events observed at any time during the studies.
The Eprinomectin ERI-treated cattle were not reported
as showing clinical signs of parasitic disease, but control
animals in Studies 1 and 2 became sufﬁciently para-
sitized to compromise their well being with one animal
dying from dictyocaulosis and parasitic gastroenteritis in
Study 2. Therefore, salvage treatments with fenbendazole
(PANACUR® 10% suspension; Intervet, B.V.) according to
the manufacturer’s recommendation were administered
orally to all controls on Days 58, 85 and 101 in Study 1,
and on Day 56 in Study 2.
As summarized in Table 2, cattle treated with Epri-
nomectin ERI had signiﬁcantly (p < 0.05) fewer strongylid
eggs than the vehicle-treated (control) cattle at each
post-treatment time point, if present. Eprinomectin ERI
treatment suppressed nematode egg production consis-
tently through all study sites, and efﬁcacy was  ≥94% for
all post-treatment time points. Nematodirus eggs were
observed infrequently at fecal examinations so meaning-
ful analysis of that parasite was possible only on data
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Table 2
Summary of fecal egg and larval count data.
Study #A TreatmentB Eggs or larvae per gram counts (GMC)
Efﬁcacy (%)D
Days before treatment Days after treatment
−15, −14 or −7 0 28 56 84 120
Strongylid eggs
1 Control 0 0 194 390 180 5
EpERI 0a 0a 0b <1b <1b 0b
naE na 100% >99% >99% 100%
2 Control 0 0 45 634 493 212
EpERI 0a 0a 0b 0b <1b <1b
na na 100% 100% >99% >99%
3 Control 0 0 102 185 192 221
EpERI 0a <1a <1b <1b 1b 1b
na na >99% >99% >99% >99%
4 Control 0 0 0 1 3 13
EpERI 0a 0a 0a 0b <1b <1b
na na na 100% 94% 99%
5 Control 20.1 nsF 18.4 11.8 12.4 8.1
EpERI 20.1a ns <1b <1b <1b <1b
na na 98% 96% >99% 99%
Nematodirus spp. eggs
1 Control 0 0 –G 21 – –
EpERI 0 0 – 0b – –
na  na na 100% na na
2 Control 0 0 – 5 – –
EpERI 0 0 – 0b – –
na  na na 100% na na
3 Control 0 0 – – <1 –
EpERI 0 0 – – 0b –
na na na na 100%
4 Control 0 0 – – – 3
EpERI 0 0 – – – 0b
na na na na na 100%
Dictyocaulus spp. larvae
2 Control 0 0 4 40 <1 2
EpERI 0 0 0b 0b 0b 0b
na na 100% 100% 100% 100%
A Study sites: Study 1 – Hertfordshire, UK; Study 2 – Upper Bavaria, Germany; Study 3 – Arkansas, USA; Study 4 – Idaho, USA; Study 5 – Missouri, USA.
B Control, ERI vehicle-treated; EpERI, Eprinomectin ERI.
C Geometric mean strongylid and Nematodirus egg and Dictyocaulus larval counts (based on transformation to the natural logarithm of [count + 1]).
D Efﬁcacy = 100 [(geometric mean control − geometric mean Eprinomectin ERI)/geometric mean control].
E Not applicable.
F
5.
c
n
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c
c
c
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N
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eNot sampled.
G Not analyzed due to a prevalence of <40% in the control group.
a Probability from the Wilcoxon rank sum test: not signiﬁcant at  ˛ = 0.0
b Probability from the Wilcoxon rank sum test: p < 0.05.
ollected at some time points; cattle treated with Epri-
omectin ERI had signiﬁcantly (p < 0.05) fewer Nematodirus
ggs than the control cattle at Days 56 (Studies 1 and 2), 84
Study 3), and 120 (Study 4) with 100% reduction in egg
ounts. Cattle treated with Eprinomectin ERI had signiﬁ-
antly (p < 0.05) fewer Dictyocaulus larvae than the control
attle at each post-treatment time point in Study 2 with
00% efﬁcacy (p < 0.05) for all post-treatment time points.
o lungworm larvae were recovered from any fecal sample
ollected from Eprinomectin ERI-treated animals follow-
ng treatment. Strongyloides, Capillaria, and/or Trichuris spp.
ggs were found in some animals in some studies; how-
ver, there were insufﬁcient numbers of animals presentwith those eggs for a reliable assessment. The summary of
the fecal strongylid and Nematodirus egg and Dictyocaulus
larval count data for all studies is shown in Table 2.
The pepsinogen concentration as measured in Study
2 animals was signiﬁcantly (p < 0.05) higher in the ERI
vehicle-treated (control) cattle than in the cattle treated
with Eprinomectin ERI at Days 56, 84 and 120. For the con-
trols, the mean plasma pepsinogen concentration rose from
307 mU/mL tyrosine at turnout to 2827 mU/mL  tyrosine at
removal from pasture on Day 120. For the Eprinomectin
ERI-treated cattle, the mean plasma pepsinogen concen-
tration was 260 mU/mL  tyrosine at turnout and did not rise
higher than 1604 mU/mL  tyrosine at housing.
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Table 3
Mean nematode worm counts for pairs of tracers which grazed with the principals for the indicated intervals, were removed from pasture and humanely
euthanized after housing for 20/21 days – Study 1 (Hertfordshire, UK).
Interval (study days) pairs of tracers grazed
0–28 28–56 56–84a 84–98b
Cooperia oncophora 3672 22,123 72,349 125,966
Cooperia surnabada 298 387 5151 107,384
Cooperia spp., L4c 30 1200 4370 39,600
Nematodirus helvetianus 800 6140 4980 85,200
Nematodirus spp., L4 140 2510 1520 6800
Ostertagia lyrata 20 1070 1956 5927
Ostertagia ostertagi 1981 98,050 68,164 202,733
Trichostrongylus axei 0 0 730 0
.a Necropsied three and seven days after removal of calves from pasture
b Necropsied one day after removal of calves from pasture.
c Fourth stage larvae, developing and/or inhibited.
In addition to the fecal egg and larval counts of
the control cattle in all studies from Day 28 for-
ward, the parasite counts of the tracer cattle in Studies
1–4 (Tables 3–6)  further documented that the pastures
remained contaminated with infective nematode lar-
vae and conﬁrmed that challenge exposure was present
for the entire grazing period. The mean total tracer
cattle nematode recoveries at necropsy indicated a heav-
ier challenge in the two studies conducted in Europe
(Tables 3 and 4) compared to the studies conducted in the
USA (Tables 5 and 6).
At necropsy 27–30 days after removal from pasture,
cattle treated with Eprinomectin ERI and allowed to
graze naturally infected pasture for 120 days had sig-
niﬁcantly (p < 0.05) fewer of the following nematodes
than the vehicle-treated (control) cattle with over-
all reduction of nematode counts by >92% (Table 7):
Table 4
Mean nematode worm counts for pairs of tracers which grazed with the principa
euthanized after housing for 21/22 days – Study 2 (Upper Bavaria, Germany).
Interval (study days) pairs of trace
−35 to −7a 0–28 
Dictyocaulus viviparus 0 186
Bunostomum phlebotomum 0 40
Cooperia curticei 9465 1795
Cooperia oncophora 12,660 15,239
Cooperia punctata 1580 1900
Cooperia surnabada 2541 2686
Cooperia spp., L4b 0 0
Haemonchus contortus 10 245
Nematodirus battus 90 40
Nematodirus helvetianus 0 2650
Nematodirus spp., L4 645 15
Oesophagostomum radiatum 0 68
Ostertagia circumcincta 1019 0
Ostertagia leptospicularis 4231 1227
Ostertagia lyrata 0 0
Ostertagia ostertagi 16,227 2639
Ostertagia pinnata 172 0
Ostertagia trifurcata 172 0
Ostertagia spp., L4 11,000 200
Strongyloides papillosus 0 0
Trichostrongylus axei 516 530
Trichostrongylus colubriformis 220 0
Trichuris discolor 0 18
a Necropsied immediately after removal of calves from pasture.
b Fourth stage larvae, developing and/or inhibited.Dictyocaulus viviparus (adults and fourth-stage larvae),
Bunostomum phlebotomum,  Cooperia curticei, Cooperia
oncophora,  Cooperia punctata, Cooperia surnabada,  Cooperia
spp. inhibited fourth-stage larvae, Haemonchus contortus,
Haemonchus placei, Haemonchus spp. inhibited fourth-
stage larvae, Nematodirus helvetianus, Nematodirus spp.
inhibited fourth-stage larvae, Oesophagostomum radia-
tum, Oesophagostomum spp. inhibited fourth-stage lar-
vae, Ostertagia leptospicularis,  Ostertagia lyrata,  Ostertagia
ostertagi, Ostertagia spp. inhibited fourth-stage larvae,
Trichostrongylus axei, Trichostrongylus colubriformis, Tri-
chostrongylus spp. inhibited fourth-stage larvae, Trichuris
discolor, and Trichuris ovis.Pre-treatment bodyweight was  similar for the Epri-
nomectin ERI-treated and ERI vehicle-treated (control)
animals in all study groups. During the 120-day graz-
ing period following treatment, Eprinomectin ERI-treated
ls for the indicated intervals, were removed from pasture and humanely
rs grazed
28–56 56–84 84–112
 1592 687 434
 0 50 50
 3320 10,230 7745
 8787 39,381 13,640
 8540 24,125 21,875
 1198 6325 2626
 0 520 195
 40 95 50
 0 10 0
 820 530 560
 80 240 280
 18 65 57
 0 0 0
 2887 3950 4996
 0 11 24
 7938 25,580 23,616
 0 0 0
 0 0 0
 40 935 24,015
 15 390 0
 655 1870 3485
 0 0 0
 32 7 10
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Table 5
Mean nematode worm counts for pairs of tracers which grazed with the principals for the indicated intervals, were removed from pasture and humanely
euthanized after housing for 21/22 days – Study 3 (Arkansas, USA).
Interval (study days) pairs of tracers grazed
−35 to −7a 0–28 28–56 56–84 84–112
Dictyocaulus viviparus 4 0 0 0 5
Bunostomum phlebotomum,  L4b 17 0 0 0 0
Cooperia oncophora 4709 8035 3914 3196 0
Cooperia punctata 1616 2931 1847 18,535 12,176
Cooperia surnabada 1352 978 473 261 0
Cooperia spp., L4 1897 63 2 331 145
Haemonchus placei 0 380 143 283 513
Haemonchus spp., L4 0 10 11 0 31
Nematodirus helvetianus 100 627 552 1611 0
Nematodirus spp., L4 227 49 101 650 20
Oesophagostomum radiatum 0 101 40 331 0
Oesophagostomum radiatum, L4 <1 11 <1 40 22
Ostertagia lyrata 8 22 40 3 2
Ostertagia ostertagi 268 2517 1689 3752 501
Ostertagia spp., L4 2160 718 25 173 2
Trichostrongylus axei 5 37 39 14 16
Trichostrongylus colubriformis 0 34 0 0 0
Trichuris spp. 0 2 81 0 0
a Necropsied immediately after removal of calves from pasture.
b Fourth stage larvae, developing and/or inhibited.
Table 6
Mean nematode worm counts for pairs of tracers which grazed with the principals for the indicated intervals, were removed from pasture and humanely
euthanized after housing for 21/22 days – Study 4 (Idaho, USA).
Interval (study days) pairs of tracers grazed
−35 to −5a 0–28 28–56 56–84 84–112
Cooperia oncophora 50 0 0 120 20
Nematodirus helvetianus 10 30 60 510 0
Nematodirus spp., L4b 0 0 40 0 0
Ostertagia ostertagi 70 60 80 470 1320
Ostertagia spp., L4 250 30 0 0 10
0 
c
t
g
a
a
4
s
o
o
p
t
o
s
l
b
o
r
n
d
3Trichuris spp. 0 
a Necropsied immediately after removal of calves from pasture.
b Fourth stage larvae, developing and/or inhibited.
attle gained on average between 4.8 and 41.0 kg more than
he respective controls. Day 120 bodyweight and weight
ain until Day 120 was signiﬁcantly (p < 0.05) greater for
nimals treated with Eprinomectin ERI than for the control
nimals in three studies (Table 8).
. Discussion
The design of the long-term natural nematode challenge
tudies with the use of one pasture for all animals and pairs
f tracer cattle grazing the same pasture excluded the factor
f “pasture” (Bransby, 1993) and as a result also provided a
recise assessment of the level of pasture infectivity with
he species that were most abundant throughout the course
f the study.
In all studies, Eprinomectin ERI-treated animals were
ubjected to continuous nematode larval and/or egg chal-
enge throughout the 120-day grazing period, as shown
y control egg and larval counts and/or by the numbers
f nematodes recovered from the tracer cattle. Nematode
ecoveries from tracer cattle in Studies 1–4 indicated that
ematode challenge was severe in the two studies con-
ucted in Europe, while challenge was lower in Studies
 and 4. The tracer animal data also conﬁrmed that the13 5 8
identiﬁed spectrum of nematodes, including Cooperia spp.
and O. ostertagi as main components of the total gas-
trointestinal parasite burdens, was representative of those
species known to cause clinical disease or subclinical para-
sitism and poor productivity in grazing cattle in temperate
regions (Sutherland and Scott, 2010).
Based on repeated fecal examinations throughout all
studies and nematode recoveries from the cattle removed
from pasture 120 days after treatment administration,
this series of studies conducted at different geographical
locations in the USA and in Europe consistently demon-
strated a high level of continuous efﬁcacy of Eprinomectin
ERI against a wide range of gastrointestinal and pul-
monary nematode parasites of grazing cattle. A weight
gain advantage of the Eprinomectin ERI treatment was evi-
dent in comparison to vehicle-treated controls. The results
of the necropsy of the study animals after removal from
pasture conﬁrmed the results of the fecal examinations.
Administration of Eprinomectin ERI not only provides efﬁ-
cacious treatment of existing adult, normally developing
and inhibited immature nematode stages (Hunter et al.,
2013; Rehbein et al., 2013) as has been documented for
the eprinomectin pour-on formulation (Shoop et al., 1996;
Gogolewski et al., 1997a,b; Pitt et al., 1997; Williams et al.,
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Table 7
Burden of gastrointestinal and pulmonary nematodes of cattle after grazing for 120 days following treatment.
Studya Control (ERI vehicle) Eprinomectin ERI Efﬁcacyd Probabilitye
Prevalenceb GMc Prevalence GM
Dictyocaulus viviparus
2  13/14f 10 0/15 0 100% <0.05
3  13/15 5 1/15 <1 97% <0.05
4  15/15 5 2/15 <1 98% <0.05
5 4/15 <1 0/15 0 –g nah
Dictyocaulus viviparus, fourth-stage larvae
4 2/15 <1 0 0 – na
5  6/15 <1 0 0 100% <0.05
Bunostomum phlebotomum
2  9/14f 10 0/15 0 100% <0.05
3  2/15 <1 0/15 0 – na
5  7/15 <1 0/15 0 100% <0.05
Capillaria spp.
3  3/15 <1 0/15 0 – na
5 1/15 <1 0/15 0 – na
Cooperia curticei
2  13/14f 564 0/15 0 100% <0.05
Cooperia oncophora
1  14/15 1288 2/15 <1 >99% <0.05
2 13/14f 2109 2/15 <1 >99% <0.05
3  7/15 21 7/15 3 84% nsi
4 14/15 459 1/15 <1 >99% <0.05
Cooperia punctata
2  14/14f 34,183 6/15 4 >99% <0.05
3  15/15 1785 15/15 280 84% ns
Cooperia surnabada
1 12/15 107 0/15 0 100% <0.05
2  11/14f 350 2/15 <1 >99% <0.05
3 4/15  5 4/15 <1 – na
4  8/15 13 1/15 <1 99% <0.05
Cooperia spp., inhibited fourth-stage larvae
1  11/15 244 0/15 0 100% <0.05
2 13/14f 199 1/15 <1 >99% <0.05
3  13/15 48 5/15 2 95% <0.05
4  3/15 1 0/15 0 – na
Haemonchus contortus
2 9/14f 9 0/15 0 100% <0.05
Haemonchus placei
3  15/15 616 7/15 7 99% <0.05
4  2/15 <1 0/15 0 – na
5  6/15 4 0/15 0 100% <0.05
Haemonchus spp., inhibited fourth stage larvae
3  9/15 5 0/15 0 100% <0.05
5  10/15 22 1/15 <1 99% <0.05
Nematodirus helvetianus
1  7/15 24 2/15 <1 97% <0.05
2  9/14f 14 2/15 <1 97% <0.05
3 2/15  1 1/15 <1 – na
4  6/15 9 0/15 0 100% <0.05
Nematodirus spp., inhibited fourth-stage larvae
1  8/15 24 0/15 0 100% <0.05
2  5/14f 5 1/15 <1 – na
3  3/15 <1 0/15 0 – na
4  1/15 <1 0/15 0 – na
Oesophagostomum radiatum
1 2/15 <1 0/15 0 – na
2  14/14f 66 0/15 0 100% <0.05
3 12/15  70 3/15 1 99% <0.05
4 4/15  <1 0/15 0 – na
5  12/15 21 0/15 0 100% <0.05
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Table 7 (Continued)
Studya Control (ERI vehicle) Eprinomectin ERI Efﬁcacyd Probabilitye
Prevalenceb GMc Prevalence GM
Oesophagostomum spp., inhibited fourth-stage larvae
3 14/15 21 4/15 1 95% <0.05
5  3/15 <1 0/15 0 – na
Ostertagia leptospicularis
2 13/14f 698 2/15 <1 >99% <0.05
Ostertagia lyrata
1 14/15 121 0/15 0 100% <0.05
3  15/15 139 4/15 <1 >99% <0.05
5  4/15 2 1/15 <1 – na
Ostertagia ostertagi
1 15/15 12,537 1/15 <1 >99% <0.05
2  14/14f 4961 2/15 <1 >99% <0.05
3  15/15 3381 10/15 8 >99% <0.05
4  15/15 1774 1/15 <1 >99% <0.05
5 15/15 823 2/15 <1 >99% <0.05
Ostertagia spp., inhibited fourth-stage larvae
1 15/15 6261 0/15 0 100% <0.05
2 14/14f 14,703 4/15 4 >99% <0.05
3  9/15 2 0/15 0 100% <0.05
4  1/15 <1 0/15 0 – na
5 15/15 389 1/15 <1 >99% <0.05
Ostertagia spp., developing (late) fourth-stage larvae
3  14/15 9 2/15 <1 98% <0.05
4  4/15 1 0/15 0 – na
Strongyloides papillosus
3 2/15 1 0/15 0 – na
Trichostrongylus axei
2 14/14f 3125 6/15 5 >99% <0.05
3  15/15 108 3/15 <1 >99% <0.05
Trichostrongylus colubriformis
3 6/15 2 0/15 0 100% <0.05
5  1/15 <1 1/15 <1 – na
Trichostrongylus spp.
4 5/15 2 1/15 <1 – na
Trichostrongylus spp., inhibited fourth stage larvae
3  3/15 <1 0/15 0 – na
5  12/15 27 0/15 0 100% <0.05
Trichuris discolor
2 14/14f 50 7/15 4 92% <0.05
Trichuris ovis
4 12/15 45 6/15 2 95% <0.05
a Study sites: Study 1 – Hertfordshire, UK; Study 2 – Upper Bavaria, Germany; Study 3 – Arkansas, USA; Study 4 – Idaho, USA; Study 5 – Missouri, USA.
b Prevalence: Number of cattle infected/Number of cattle in group.
c Geometric mean counts (based on transformation to the natural logarithm of [count + 1]).
d Efﬁcacy = 100 [(geometric mean control − geometric mean Eprinomectin ERI)/geometric mean control].
e Probability from the Wilcoxon rank sum test.
f One animal from the control group died on Study Day 56.
1
l
i
e
e
w
t
i
eg Not calculated due to a prevalence of <40% in the control group.
h Not analyzed.
i Not signiﬁcant at  ˛ = 0.05.
997; Yazwinski et al., 1997), but also prevented the estab-
ishment of inhibited larvae of several nematode genera,
ncluding the accumulation of the most important arrested
arly fourth-stage larvae of Ostertagia spp. Before humane
uthanasia, all study animals were kept for about four
eeks under conditions designed to prevent further nema-
ode infections, thus allowing normally developing and
nhibited nematode larvae to be distinguished (Williams
t al., 1997).Consistent with the results collected in ﬁeld studies
(Kunkle et al., 2013), the fecal output of nematode eggs
and lungworm larvae from Eprinomectin ERI-treated cat-
tle was  very low or zero throughout the study period. This
effect will be beneﬁcial to reducing pasture contamination.
Grazing cattle treated with Eprinomectin ERI are protected
from establishment of incoming larvae, and this protec-
tion will thus reduce the contamination of the pasture and
transmission of nematode parasites.
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Table 8
Summary of bodyweight and weight gain data.
Studya Treatmentb Mean Day −3/−1/0
Bodyweight (kg)c
Probabilityd
Mean Day 120
Bodyweight (kg)
Probability
Mean weight gain
(kg) to Day 120
Probability
1 Control, n = 15 145.6 161.0 15.4
EpERI, n = 15 146.3 176.8 30.5
nse p < 0.05 p < 0.05
2 Control, n = 15f 139.3 165.8 26.6
EpERI, n = 15 139.5 207.1 67.6
ns p < 0.05 p < 0.05
3 Control, n = 15 165.7 197.2 31.5
EpERI, n = 15 165.2 201.5 36.3
ns ns ns
4 Control, n = 15 216.2 246.2 29.9
EpERI, n = 15 214.5 250.4 36.0
ns ns ns
5 Control, n = 15 234.3 271.9 37.6
EpERI, n = 15 234.9 295.5 60.6
ns p < 0.05 p < 0.05
a Study sites: Study 1 – Hertfordshire, UK; Study 2 – Upper Bavaria, Germany; Study 3 – Arkansas, USA; Study 4 – Idaho, USA; Study 5 – Missouri, USA.
b Control = vehicle-treated; EpERI = Eprinomectin ERI.
c Least squares means rounded to one degree of precision post-calculation.
g Eprinod Signiﬁcant probability values from Wilcoxon rank sum test comparin
e Not signiﬁcant at  ˛ = 0.05.
f One animal from the control group died on Study Day 56.
The plasma pepsinogen levels in the treated cattle
in Study 2 suggest that the prophylaxis provided by
Eprinomectin ERI prevented pathology to the abomasum
associated with infection with abomasal parasites, espe-
cially O. ostertagi (Vercruysse and Claerebout, 2001).
The high prophylactic anthelmintic efﬁcacy of Epri-
nomectin ERI demonstrated in the present studies was
reﬂected in an improved rate of weight gain of Epri-
nomectin ERI-treated versus vehicle-treated cattle. This
result conﬁrms the results of other studies using Epri-
nomectin ERI under natural challenge conditions (Kunkle
et al., 2013) and numerous studies in which an ivermectin
intraruminal slow-release bolus has been used to control
nematode infection in young stock (e.g., Jacobsen et al.,
1995; Pitt et al., 1996; Forbes et al., 2002). This effect is
consistent with the growth response following repeated
strategic anthelmintic treatments in ﬁrst season grazing
cattle (Shaw et al., 1998). The higher beneﬁt of Epri-
nomectin ERI treatment on weight gain observed in Studies
1 and 2 compared to Studies 3 and 4 can be explained by
the substantially lower nematode challenge in the latter
studies as reﬂected in the total nematode burdens acquired
by the tracer cattle and the composition of the nematode
population.
In conclusion, the results of the series of controlled stud-
ies reported here demonstrate the very high efﬁcacy and
acceptability of Eprinomectin ERI when administered sub-
cutaneously at 1.0 mg/kg bodyweight to cattle against a
wide range of gastrointestinal and pulmonary nematode
infections under natural nematode challenge conditions
for 120 days. With its extended activity, Eprinomectin ERI
offers a highly effective product which can be conveniently
administered to control the most important parasitic infec-
tions of grazing cattle for at least 4 months after treatment.
®All marks are the property of their respective owners.mectin ERI to controls are rounded to 0.05.
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